Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $27.7050 (2.38%) ($27.4200 - $27.9900) on Mon. Sep. 14, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.33% (three month average) | RSI | 49 | Latest Price | $27.7050(2.38%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | HALO declines -1.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(41%) | Factors Impacting HALO price | HALO will decline at least -1.165% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) EDOC(-4%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.165% (StdDev 2.33%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $24.26(-12.43%) | Resistance Level | $28.01 | 5 Day Moving Average | $27.5(0.75%) | 10 Day Moving Average | $27.86(-0.56%) | 20 Day Moving Average | $28.01(-1.09%) | To recent high | -6.4% | To recent low | 19.7% | Market Cap | $3.786b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |